LobbyingHorizon Therapeutics Horizon Pharma USA lobbying by quarter
Horizon Therapeutics Horizon Pharma USA's latest lobbying report covers Q4 2023, at $30K. Its first report covers Q4 2022.
Horizon Therapeutics Horizon Pharma USA
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $80K | 1 |
| Q1 2023 | $90K | 1 |
| Q2 2023 | $90K | 1 |
| Q3 2023 | $90K | 1 |
| Q4 2023 | $30K | 1 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
No issue reported.
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
No house or agency named.
Firms it paid
| Firm | ||
|---|---|---|
| Sonoran Policy Group, LLC D/B/A Stryk Global Diplomacy, Formerly Known As Sonora | $380K | 5 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/01/21for Q4 2023 | Sonoran Policy Group, LLC D/B/A Stryk Global Diplomacy, Formerly Known As Sonora | $30K |
| 23/10/16for Q3 2023 | Sonoran Policy Group, LLC D/B/A Stryk Global Diplomacy, Formerly Known As Sonora | $90K |
| 23/07/13for Q2 2023 | Sonoran Policy Group, LLC D/B/A Stryk Global Diplomacy, Formerly Known As Sonora | $90K |
| 23/04/19for Q1 2023 | Sonoran Policy Group, LLC D/B/A Stryk Global Diplomacy, Formerly Known As Sonora | $90K |
| 23/01/20for Q4 2022 | Sonoran Policy Group, LLC D/B/A Stryk Global Diplomacy, Formerly Known As Sonora | $80K |